Professor Julian Gillmore / Mathew S. Maurer, MD - Exploring New Paradigms in Transthyretin Cardiac Amyloidosis Care: Experts vs AI| Listen on Anghami

Nov 2025

Toby Maher, MD, MSc, PhD - Clearing the Air on Fibrosing ILDs: Pulmonologist Conversations on Timely Diagnosis and Modern Care With Antifibrotic Therapy

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA infor ... Show More

56m 46s

Nov 2025

Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy Platforms

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA infor ... Show More

49m 48s

Nov 2025

John B. Buse, MD, PhD / Pam R. Taub, MD, FACC, FASPC - To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA infor ... Show More

1h 3m

Oct 2025

Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE i ... Show More

41m 33s

Aug 2025

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - Leading the Next Chapter of Myeloma Care: Oncology Nurse Stewardship in the Era of Innovative Antibodies and Cellular Therapies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD information, and to app ... Show More

54m 48s

Oct 2025

Peter A. Campochiaro, MD - Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE informati ... Show More

58m 50s

May 2022

Bradley J. Monk, MD, FACS, FACOG - When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum

Go online to PeerView.com/YWA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you optimizing the care of your patients with ovarian cancer with poly (ADP-ribose) polymerase (PARP) inhibitors and novel therapies such as tu ... Show More

56m 25s

Aug 2023

Immunotherapy in TNBC: What's New, What's Next?

Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991253). The ... Show More

20m 52s

Mar 2022

Richard S. Finn, MD - Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape

Go online to PeerView.com/VMC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.Are you prepared to implement the latest recommended therapies into your hepatocellular carcinoma (HCC) practice? With several available treatment m ... Show More

1h 35m

Mar 2022

Robert Dreicer, MD, MS, MACP, FASCO - Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults

Go online to PeerView.com/GZF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Clinicians who treat patients with prostate cancer have new opportunities to improve outcomes across a variety of settings, but the rapid expansion ... Show More

1h 21m

Apr 2022

Pasi A. Jänne, MD, PhD - Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies

Go online to PeerView.com/ZGP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The treatment arsenal for non–small cell lung cancer (NSCLC) with and without genomic alterations continues to expand, and novel HER2-, HER3-, and ... Show More

57m 55s

Dec 2023

Thinking Beyond TROP2 at ESMO 2023

What were the biggest takeaways from ESMO 2023 related to TNBC and IBC? Tune in to hear experts Drs Kevin Kalinsky and Filipa Lynce discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991259). The topics and dis ... Show More

17m 6s

Professor Julian Gillmore / Mathew S. Ma...